These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 512844)

  • 1. Chlorpheniramine. II. Effect of the first-pass metabolism on the oral bioavailability in dogs.
    Athanikar NK; Chiou WL
    J Pharmacokinet Biopharm; 1979 Aug; 7(4):383-96. PubMed ID: 512844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of chlorpheniramine after intravenous and oral administration in normal adults.
    Huang SM; Athanikar NK; Sridhar K; Huang YC; Chiou WL
    Eur J Clin Pharmacol; 1982; 22(4):359-65. PubMed ID: 7106172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior of chlorpheniramine in vivo after administration of d- and l-chlorpheniramine maleate].
    Fujiwara K; Iwamoto K; Kawai S; Sakamoto T
    Yakugaku Zasshi; 1989 Jan; 109(1):59-64. PubMed ID: 2732905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral absorption and presystemic first-pass effect of chlorpheniramine in rabbits.
    Huang SM; Huang YC; Chiou WL
    J Pharmacokinet Biopharm; 1981 Dec; 9(6):725-38. PubMed ID: 7341757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of chlorpheniramine maleate in the dog and rat.
    Peets EA; Weinstein R; Billard W; Symchowicz S
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):172-90. PubMed ID: 5072184
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioavailability of regular and controlled-release chlorpheniramine products.
    Kotzan JA; Vallner JJ; Stewart JT; Brown WJ; Viswanathan CT; Needham TE; Dighe SV; Malinowski R
    J Pharm Sci; 1982 Aug; 71(8):919-23. PubMed ID: 7120098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of intravenous chlorpheniramine in children.
    Thompson JA; Bloedow DC; Leffert FH
    J Pharm Sci; 1981 Nov; 70(11):1284-6. PubMed ID: 7299679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of d-chlorpheniramine following intravenous and oral administration in healthy Thoroughbred horses.
    Kuroda T; Nagata S; Takizawa Y; Tamura N; Kusano K; Mizobe F; Hariu K
    Vet J; 2013 Aug; 197(2):433-7. PubMed ID: 23489843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute bioavailability study in the dog with Visacor, a new cardioselective beta blocking drug with intrinsic sympathomimetic activity.
    McAinsh J; Smith RP; Ferguson RA
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):129-39. PubMed ID: 6146530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and tissue distribution of chlorpheniramine in rabbits after intravenous administration.
    Huang SM; Chiou WL
    J Pharmacokinet Biopharm; 1981 Dec; 9(6):711-23. PubMed ID: 7341756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, bioavailability, and hemodynamic effects of trazodone after intravenous and oral administration of a single dose to dogs.
    Jay AR; Krotscheck U; Parsley E; Benson L; Kravitz A; Mulligan A; Silva J; Mohammed H; Schwark WS
    Am J Vet Res; 2013 Nov; 74(11):1450-6. PubMed ID: 24168312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs.
    Supko JG; Garcia-Carbonero R; Puchalski TA; Malspeis L
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):202-8. PubMed ID: 11592341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of chlorpheniramine maleate in man.
    Peets EA; Jackson M; Symchowicz S
    J Pharmacol Exp Ther; 1972 Feb; 180(2):364-74. PubMed ID: 5010678
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical pharmacokinetics of chlorpheniramine.
    Rumore MM
    Drug Intell Clin Pharm; 1984 Sep; 18(9):701-7. PubMed ID: 6383755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.
    Patel IH; Levy RH; Bauer TG
    Epilepsia; 1975 Dec; 16(5):705-16. PubMed ID: 816644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood levels following multiple oral dosing of chlorpheniramine conventional and controlled release preparations.
    Vallner JJ; Kotzan JA; Stewart JT; Brown WJ; Honigberg IL; Needham TE; Dighe SV
    Biopharm Drug Dispos; 1982; 3(2):95-104. PubMed ID: 7104467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optical resolution of racemic chlorpheniramine and its stereoselective pharmacokinetics in rat plasma.
    Sakurai E; Yamasaki S; Iizuka Y; Hikichi N; Niwa H
    J Pharm Pharmacol; 1992 Jan; 44(1):44-7. PubMed ID: 1350627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic studies of pentylenetetrazol in dogs.
    Jun HW
    J Pharm Sci; 1976 Jul; 65(7):1038-41. PubMed ID: 957110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.